For: | Zheng SG, Xu HX, Lu MD, Xie XY, Xu ZF, Liu GJ, Liu LN. Role of contrast-enhanced ultrasound in follow-up assessment after ablation for hepatocellular carcinoma. World J Gastroenterol 2013; 19(6): 855-865 [PMID: 23430451 DOI: 10.3748/wjg.v19.i6.855] |
---|---|
URL: | https://www.wjgnet.com/1007-9327/full/v19/i6/855.htm |
Number | Citing Articles |
1 |
Evaluation of tumor response to intra-arterial chemoembolization of hepatocellular carcinoma: Comparison of contrast-enhanced ultrasound with multiphase computed tomography. Diagnostic and Interventional Imaging 2017; 98(3): 253 doi: 10.1016/j.diii.2016.09.002
|
2 |
Chia‐Chi Wang. Contrast‐enhanced ultrasound for hepatocellular carcinoma: Focusing on unique benefits and indications. Advances in Digestive Medicine 2019; 6(1): 3 doi: 10.1002/aid2.13111
|
3 |
Masatoshi Kudo. Drug-Off Criteria in Patients with Hepatocellular Carcinoma Who Achieved Clinical Complete Response after Combination Immunotherapy Combined with Locoregional Therapy. Liver Cancer 2023; 12(4): 289 doi: 10.1159/000532023
|
4 |
Amy K. Kim, Michael L. Schilsky. Radiology in Transplant. Current Transplantation Reports 2014; 1(4): 238 doi: 10.1007/s40472-014-0034-5
|
5 |
Christoph F. Dietrich, Christian Pállson Nolsøe, Richard G. Barr, Annalisa Berzigotti, Peter N Burns, Vito Cantisani, Maria Cristina Chammas, Nitin Chaubal, Byung Ihn Choi, Dirk-André Clevert, Xinwu Cui, Yi Dong, Mirko D’Onofrio, J. Brian Fowlkes, Odd Helge Gilja, Pintong Huang, Andre Ignee, Christian Jenssen, Yuko Kono, Masatoshi Kudo, Nathalie Lassau, Won Jae Lee, Jae Young Lee, Ping Liang, Adrian Lim, Andrej Lyshchik, Maria Franca Meloni, Jean Michel Correas, Yasunori Minami, Fuminori Moriyasu, Carlos Nicolau, Fabio Piscaglia, Adrian Saftoiu, Paul S. Sidhu, Ioan Sporea, Guido Torzilli, Xiaoyan Xie, Rongqin Zheng. Guidelines and Good Clinical Practice Recommendations for Contrast Enhanced Ultrasound (CEUS) in the Liver – Update 2020 – WFUMB in Cooperation with EFSUMB, AFSUMB, AIUM, and FLAUS. Ultraschall in der Medizin - European Journal of Ultrasound 2020; 41(05): 562 doi: 10.1055/a-1177-0530
|
6 |
Pankaj Gupta, Naveen Kalra, Sreedhara B. Chaluvashetty, Shivanand Gamangatti, Amar Mukund, Razik Abdul, VS Shyam, Sanjay Saran Baijal, Chander Mohan. Indian College of Radiology and Imaging Guidelines on Interventions in Hepatocellular Carcinoma. Indian Journal of Radiology and Imaging 2022; 32(04): 540 doi: 10.1055/s-0042-1754361
|
7 |
Xiaohong Xu, Liangping Luo, Jiexin Chen, Jiexin Wang, Honglian Zhou, Mingyi Li, Zhanqiang Jin, Nianping Chen, Huilai Miao, Manzhou Lin, Wei Dai, Anil T. Ahuja, Yi-Xiang J. Wang. Acoustic Radiation Force Impulse Elastography for Efficacy Evaluation after Hepatocellular Carcinoma Radiofrequency Ablation: A Comparative Study with Contrast-Enhanced Ultrasound. BioMed Research International 2014; 2014: 1 doi: 10.1155/2014/901642
|
8 |
Davide Roccarina, Matteo Garcovich, Maria Elena Ainora, Laura Riccardi, Maurizio Pompili, Antonio Gasbarrini, Maria Assunta Zocco. Usefulness of contrast enhanced ultrasound in monitoring therapeutic response after hepatocellular carcinoma treatment. World Journal of Hepatology 2015; 7(14): 1866-1874 doi: 10.4254/wjh.v7.i14.1866
|
9 |
Yang Hai, Esika Savsani, Weelic Chong, John Eisenbrey, Andrej Lyshchik. Meta-analysis and systematic review of contrast-enhanced ultrasound in evaluating the treatment response after locoregional therapy of hepatocellular carcinoma. Abdominal Radiology 2021; 46(11): 5162 doi: 10.1007/s00261-021-03248-9
|
10 |
Lucia Cerrito, Maria Elena Ainora, Giuseppe Cuccia, Linda Galasso, Irene Mignini, Giorgio Esposto, Matteo Garcovich, Laura Riccardi, Antonio Gasbarrini, Maria Assunta Zocco. Dynamic Contrast-Enhanced Ultrasound in the Prediction of Advanced Hepatocellular Carcinoma Response to Systemic and Locoregional Therapies. Cancers 2024; 16(3): 551 doi: 10.3390/cancers16030551
|
11 |
Jin-Yu Wu, Xiu-Mei Bai, Hong Wang, Qian Xu, Song Wang, Wei Wu, Kun Yan, Wei Yang. The Perfusion Features of Recurrent Hepatocellular Carcinoma After Radiofrequency Ablation Using Contrast-Enhanced Ultrasound and Pathological Stemness Evaluation: Compared to Initial Tumors. Frontiers in Oncology 2020; 10 doi: 10.3389/fonc.2020.01464
|
12 |
Mostafa Atri, Abdulmohsen Alrashed, Ahmad Hassan, Korosh Khalili, Tae Kyoung Kim, Huynh Jung Jang. Negative Predictive Value of Contrast-Enhanced Ultrasound of Liver and Kidney Thermal Ablation Sites for Local Tumour Progression during Long-term Follow-up: A Retrospective Consecutive Study. Canadian Association of Radiologists Journal 2019; 70(4): 434 doi: 10.1016/j.carj.2019.06.011
|
13 |
Li Chen, Zhi-xing Liu, Qiu-chen Bi, Jun Zhao, Qing-rong Liang, Qun Tang. Ultrasound-Guided Percutaneous Ethanol-Paclitaxel Combined Therapy for Rabbit VX2 Liver Tumors. Journal of Hepatocellular Carcinoma 2021; : 263 doi: 10.2147/JHC.S301083
|
14 |
Christoph F. Dietrich, Christian Pállson Nolsøe, Richard G. Barr, Annalisa Berzigotti, Peter N. Burns, Vito Cantisani, Maria Cristina Chammas, Nitin Chaubal, Byung Ihn Choi, Dirk-André Clevert, Xinwu Cui, Yi Dong, Mirko D'Onofrio, J. Brian Fowlkes, Odd Helge Gilja, Pintong Huang, Andre Ignee, Christian Jenssen, Yuko Kono, Masatoshi Kudo, Nathalie Lassau, Won Jae Lee, Jae Young Lee, Ping Liang, Adrian Lim, Andrej Lyshchik, Maria Franca Meloni, Jean Michel Correas, Yasunori Minami, Fuminori Moriyasu, Carlos Nicolau, Fabio Piscaglia, Adrian Saftoiu, Paul S. Sidhu, Ioan Sporea, Guido Torzilli, Xiaoyan Xie, Rongqin Zheng. Guidelines and Good Clinical Practice Recommendations for Contrast-Enhanced Ultrasound (CEUS) in the Liver–Update 2020 WFUMB in Cooperation with EFSUMB, AFSUMB, AIUM, and FLAUS. Ultrasound in Medicine & Biology 2020; 46(10): 2579 doi: 10.1016/j.ultrasmedbio.2020.04.030
|
15 |
Si-Min Ruan, Mei-Qing Cheng, Hui Huang, Hang-Tong Hu, Wei Li, Xiao-Yan Xie, Ming-De Lu, Ming Kuang, Man-Xia Lin, Wei Wang. Application of the CT/MRI LI-RADS Treatment Response Algorithm to Contrast-Enhanced Ultrasound: A Feasibility Study. Journal of Hepatocellular Carcinoma 2022; : 437 doi: 10.2147/JHC.S353914
|
16 |
Vincenza Granata, Roberta Fusco, Simona Salati, Antonella Petrillo, Elio Di Bernardo, Roberta Grassi, Raffaele Palaia, Ginevra Danti, Michelearcangelo La Porta, Matteo Cadossi, Gorana Gašljević, Gregor Sersa, Francesco Izzo. A Systematic Review about Imaging and Histopathological Findings for Detecting and Evaluating Electroporation Based Treatments Response. International Journal of Environmental Research and Public Health 2021; 18(11): 5592 doi: 10.3390/ijerph18115592
|
17 |
Xiaoer Zhang, Guangliang Huang, Jieyi Ye, Ming Xu, Longfei Cong, Xujin He, Tongyi Huang, Ming Kuang, Xiaoyan Xie. 3-D Contrast-Enhanced Ultrasound Fusion Imaging: A New Technique to Evaluate the Ablative Margin of Radiofrequency Ablation for Hepatocellular Carcinoma. Ultrasound in Medicine & Biology 2019; 45(8): 1933 doi: 10.1016/j.ultrasmedbio.2019.03.019
|
18 |
Zhen Liu, Xiaofei Wang, Lei Xing, Yan Pan, Shengchuan Huang. The Application Comparison of Contrast-Enhanced Ultrasound and Contrast-Enhanced Computed Tomography in Radiofrequency Ablation Treatment for Hepatocellular Carcinoma. Cancer Biotherapy and Radiopharmaceuticals 2019; 34(10): 621 doi: 10.1089/cbr.2019.2845
|
19 |
Orlando Catalano, Francesco Izzo, Paolo Vallone, Fabio Sandomenico, Vittorio Albino, Antonio Nunziata, Roberta Fusco, Antonella Petrillo. Integrating contrast-enhanced sonography in the follow-up algorithm of hepatocellular carcinoma treated with radiofrequency ablation: single cancer center experience. Acta Radiologica 2015; 56(2): 133 doi: 10.1177/0284185114521108
|
20 |
Pankaj Gupta, Naveen Kalra, Ajay Gulati, Vishnu Dev, Ujjwal Gorsi, Sreedhara B. Cheluvashetty, Praveen Kumar-M, Ajay Duseja, Virendra Singh, Radha K. Dhiman, Manavjit Singh Sandhu. Response Assessment Following Image-Guided Therapy of Hepatocellular Carcinoma. Journal of Clinical Interventional Radiology ISVIR 2020; 4(02): 088 doi: 10.1055/s-0040-1708579
|
21 |
Richard G. Barr, Pintong Huang, Yan Luo, Xiaoyan Xie, Rongqin Zheng, Kun Yan, Xiang Jing, Yukun Luo, Huixiong Xu, Xiang Fei, Jeong Min Lee. Contrast-enhanced ultrasound imaging of the liver: a review of the clinical evidence for SonoVue and Sonazoid. Abdominal Radiology 2020; 45(11): 3779 doi: 10.1007/s00261-020-02573-9
|
22 |
Weixiang Shi, Ying He, Wenbin Ding, Shenchu Gong, Yilang Wang, Jing Xiao, Bosheng He. Contrast-enhanced ultrasonography used for post-treatment responses evaluation of radiofrequency ablations for hepatocellular carcinoma: a meta-analysis. The British Journal of Radiology 2016; 89(1064): 20150973 doi: 10.1259/bjr.20150973
|
23 |
Jeanne M. Horowitz, Ihab R. Kamel, Hina Arif-Tiwari, Sumeet K. Asrani, Nicole M. Hindman, Harmeet Kaur, Michelle M. McNamara, Richard B. Noto, Aliya Qayyum, Tasneem Lalani. ACR Appropriateness Criteria ® Chronic Liver Disease. Journal of the American College of Radiology 2017; 14(11): S391 doi: 10.1016/j.jacr.2017.08.045
|
24 |
Mariella Faccia, Matteo Garcovich, Maria Elena Ainora, Laura Riccardi, Maurizio Pompili, Antonio Gasbarrini, Maria Assunta Zocco. Contrast-Enhanced Ultrasound for Monitoring Treatment Response in Different Stages of Hepatocellular Carcinoma. Cancers 2022; 14(3): 481 doi: 10.3390/cancers14030481
|
25 |
Jeanne M. Horowitz, Ihab R. Kamel, Hina Arif-Tiwari, Sumeet K. Asrani, Nicole M. Hindman, Harmeet Kaur, Michelle M. McNamara, Richard B. Noto, Aliya Qayyum, Tasneem Lalani. ACR Appropriateness Criteria ® Chronic Liver Disease. Journal of the American College of Radiology 2017; 14(5): S103 doi: 10.1016/j.jacr.2017.02.011
|
26 |
Shu-Guang Zheng, Hui-Xiong Xu, Lin-Na Liu. Management of hepatocellular carcinoma: The role of contrast-enhanced ultrasound. World Journal of Radiology 2014; 6(1): 7-14 doi: 10.4329/wjr.v6.i1.7
|
27 |
Masatoshi Kudo, Tomoko Aoki, Kazuomi Ueshima, Kaoru Tsuchiya, Masahiro Morita, Hirokazu Chishina, Masahiro Takita, Satoru Hagiwara, Yasunori Minami, Hiroshi Ida, Naoshi Nishida, Chikara Ogawa, Tetsu Tomonari, Noriaki Nakamura, Hidekatsu Kuroda, Atsushi Takebe, Yoshifumi Takeyama, Masaaki Hidaka, Susumu Eguchi, Stephen L Chan, Masayuki Kurosaki, Namiki Izumi. Achievement of Complete Response and Drug-Free Status by Atezolizumab plus Bevacizumab Combined with or without Curative Conversion in Patients with Transarterial Chemoembolization-Unsuitable, Intermediate-Stage Hepatocellular Carcinoma: A Multicenter Proof-Of-Concept Study. Liver Cancer 2023; 12(4): 321 doi: 10.1159/000529574
|